FDCTech, the owner of CFD broker Alchemy Markets, has
secured shareholder approval to adjust its capital structure and prepare for
uplisting to a major U.S. exchange.
The company said the measures will support
acquisitions and give it flexibility to meet regulatory requirements for a
Nasdaq or NYSE listing.
Shareholder Approvals
Investors controlling most of FDCTech’s voting rights agreed to increase the authorized common stock from 500 million to 750 million and the preferred stock from 10 million to 15 million. The board also has the option to
implement a reverse stock split of between 1-for-10 and 1-for-100 before June
30, 2026.
The company stressed that the authorizations do not
change existing shareholder ownership today. Instead, they provide tools to
align with capital market standards.
FDCTech is currently listed on the OTC markets. Moving
to a national exchange would expand access to institutional investors, improve
liquidity, and increase analyst coverage. The company said management and
insiders hold a significant stake, which it described as an alignment of
interests with shareholders.
Acquisition Strategy
The firm focuses on acquiring and modernizing small
and mid-size financial services companies. It has already announced plans to
buy Sweden’s Steven AB, which operates as Xoala.
Additional deals are expected as FDCTech builds its
fintech and brokerage presence in Europe and Asia. FDCTech’s international
strategy is supported by Alchemy Markets Ltd., a Malta-based investment firm
regulated under MiFID II.
In 2023, FDCTech acquired the Alchemy Group,
which includes Alchemy Markets DMCC in the UAE, Alchemy Prime Ltd. in the UK,
and a 49.9 percent stake in Alchemy Markets Ltd. in Malta. FDCTech already
controlled the remaining 50.1 percent of the Malta-based entity, formerly known
as NSFX.
The transaction was structured as a reverse merger,
with FDCTech issuing 1.7 million shares of its Series B Preferred stock to
complete the acquisition.
Under the terms, FDCTech and Alchemy were assigned
valuations of $35 million and $350 million, respectively. Due to the
illiquidity of FDCTech shares in the OTC markets, the company did not rely on
its market price to determine the deal’s value.
FDCTech, the owner of CFD broker Alchemy Markets, has
secured shareholder approval to adjust its capital structure and prepare for
uplisting to a major U.S. exchange.
The company said the measures will support
acquisitions and give it flexibility to meet regulatory requirements for a
Nasdaq or NYSE listing.
Shareholder Approvals
Investors controlling most of FDCTech’s voting rights agreed to increase the authorized common stock from 500 million to 750 million and the preferred stock from 10 million to 15 million. The board also has the option to
implement a reverse stock split of between 1-for-10 and 1-for-100 before June
30, 2026.
The company stressed that the authorizations do not
change existing shareholder ownership today. Instead, they provide tools to
align with capital market standards.
FDCTech is currently listed on the OTC markets. Moving
to a national exchange would expand access to institutional investors, improve
liquidity, and increase analyst coverage. The company said management and
insiders hold a significant stake, which it described as an alignment of
interests with shareholders.
Acquisition Strategy
The firm focuses on acquiring and modernizing small
and mid-size financial services companies. It has already announced plans to
buy Sweden’s Steven AB, which operates as Xoala.
Additional deals are expected as FDCTech builds its
fintech and brokerage presence in Europe and Asia. FDCTech’s international
strategy is supported by Alchemy Markets Ltd., a Malta-based investment firm
regulated under MiFID II.
In 2023, FDCTech acquired the Alchemy Group,
which includes Alchemy Markets DMCC in the UAE, Alchemy Prime Ltd. in the UK,
and a 49.9 percent stake in Alchemy Markets Ltd. in Malta. FDCTech already
controlled the remaining 50.1 percent of the Malta-based entity, formerly known
as NSFX.
The transaction was structured as a reverse merger,
with FDCTech issuing 1.7 million shares of its Series B Preferred stock to
complete the acquisition.
Under the terms, FDCTech and Alchemy were assigned
valuations of $35 million and $350 million, respectively. Due to the
illiquidity of FDCTech shares in the OTC markets, the company did not rely on
its market price to determine the deal’s value.
